Psych CASC / OSCE · Psychopharmacology — clozapine
Explaining clozapine and monitoring to a family (CASC)
CASC-style communication station: shared decision on clozapine after two failed trials, monitoring plan, red flags, and balanced risk–benefit including suicide and response evidence.
On this page & tools
Target exams
Station instructions (candidate)
You have 7 minutes. Explain why clozapine is being offered after two failed adequate antipsychotic trials, what monitoring means in plain language, and which symptoms should trigger urgent contact. Balance risks (blood counts, heart inflammation early on, severe constipation) against benefits (best evidence in true treatment resistance; suicide-risk advantage in high-risk schizophrenia). Do not guarantee cure. Do not dismiss fears. Do not invent exact national blood cut-offs as universal rules — explain principles and that local protocols apply.[1][2][3]
Marking domains
Empathy and agenda setting; accurate plain-language explanation of treatment resistance and why two proper trials matter; honest description of blood monitoring ("no bloods, no drug"); first-month heart symptom red flags; bowel prevention messaging; hope without hype grounded in response-rate and InterSePT evidence; collaborative plan and written information/crisis contacts.[1][2][3][4][5]
Model communication map
- Open: thank them; check understanding of why previous medicines failed; name shared goals (clearer thinking, safety, return to study/work).[1]
- Why clozapine now: two proper medicine trials have not controlled the illness; guidelines define this as treatment-resistant schizophrenia; clozapine is the medicine with the strongest evidence in that situation — many people improve when it is used carefully.[1][2]
- Blood monitoring: regular blood tests protect against a rare but serious fall in infection-fighting cells; if bloods are not done, the medicine is not dispensed — safety system, not bureaucracy alone.[1]
- Heart vigilance: in the first weeks, fever, fast heart rate or chest pain means stop and check urgently for heart inflammation.[4]
- Bowels: constipation can become dangerous; we start bowel prevention early and want them to report problems early.[5]
- Suicide context if relevant: for some people at high suicide risk, clozapine has better evidence than olanzapine for reducing suicidal behaviour — still part of a full safety plan, not a magic shield.[3]
- Close: questions, written info, who to call, next blood date, smoking advice if applicable.[2]
Common fails
- Saying "atypicals failed so we just add three more tablets" instead of offering clozapine when TRS criteria are met.[1]
- Terrifying the family with agranulocytosis without explaining monitoring systems and benefits.[2]
- Omitting myocarditis or constipation red flags.[4][5]
- Guaranteeing cure or refusing to discuss risks.[2]
References
- [1]Howes OD, McCutcheon R, Agid O, et al. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology Am J Psychiatry, 2017.PMID 27919182
- [2]Siskind D, Siskind V, Kisely S Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis Can J Psychiatry, 2017.PMID 28655284
- [3]Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT) Arch Gen Psychiatry, 2003.PMID 12511175
- [4]Ronaldson KJ, Taylor AJ, Fitzgerald PB, et al. Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls. J Clin Psychiatry, 2010.PMID 20361910
- [5]Palmer SE, McLean RM, Ellis PM, et al. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases. J Clin Psychiatry, 2008.PMID 18452342